Castle Biosciences Competitors and Similar CompaniesClear all

Castle Biosciences's competitors and similar companies include Biocept and Veracyte.

	Castle Biosciences Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.	Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.	Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
Founding Date	Founding Date 2008	Founding Date 1993	Founding Date 2008
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech medical diagnostics medtech oncology	Tags Healthcare biotech medical diagnostics oncology	Tags Healthcare biotech genetics medical diagnostics
Locations	Locations Friendswood, US HQ Phoenix, US	Locations San Diego, US HQ	Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US
Employees	Employees 61013% increase	Employees 878% decrease	Employees 8154% increase
Valuation ($)	Valuation ($) 936.9 m	Valuation ($) N/A	Valuation ($) 2.6 b
Financial
Revenue (est.)	Revenue (est.) $344.2m (FY, 2025)	Revenue (est.) $25.9m (FY, 2022)	Revenue (est.) $517.1m (FY, 2025)
Cost of goods	Cost of goods $71m (FY, 2025)	Cost of goods $28.4m (FY, 2022)	Cost of goods N/A
Gross profit	Gross profit $273.2m (FY, 2025)	Gross profit ($2.5m) (FY, 2022)	Gross profit $362.5m (FY, 2025)
Net income	Net income ($24.2m) (FY, 2025)	Net income ($32.1m) (FY, 2022)	Net income $66.4m (FY, 2025)
Funding
Total funding raised	Total funding raised $ 46.5m	Total funding raised $ 15.9m	Total funding raised $ 116.3m